3 aggressive lymphoma that have fail at least one prior regimen of multiagent chemotherapy and patient be either ineligible for autologous bmt or autologous bmt be not recommend include hodgkin lymphoma high grade follicular lymphoma mantle cell lymphoma diffuse large b-cell lymphoma burkitt's lymphoma/leukemia anaplastic large cell lymphoma plasmablastic lymphoma peripheral t-cell lymphoma 